- Bromberger JT, Kravitz HM, Chang YF, Cyranowski JM, Brown C, Matthews KA. Major depression during and after the menopausal transition: Study of Women's Health Across the Nation (SWAN). Psychological Medicine. 2011;41(9):1879–1888. doi:10.1017/S003329171100016X
- Soares CN. Mood disorders in midlife women: understanding the critical window and its clinical implications. Menopause. 2014;21(2):198–206. doi:10.1097/GME.0000000000000193
- Gordon JL, Girdler SS, Meltzer-Brody SE, et al. Ovarian hormone fluctuation, neurosteroids, and HPA axis dysregulation in perimenopausal depression: a novel heuristic model. American Journal of Psychiatry. 2015;172(3):227–236. doi:10.1176/appi.ajp.2014.14070918
- Baglioni C, Spiegelhalder K, Lombardo C, Riemann D. Sleep and emotions: a focus on insomnia. Sleep Medicine Reviews. 2010;14(4):227–238.
- Schiller CE, Johnson SL, Abate AC, Schmidt PJ, Rubinow DR. Reproductive steroid regulation of mood and behavior. Comprehensive Physiology. 2016;6(3):1135–1160. doi:10.1002/cphy.c150014
- Stubbs B, Vancampfort D, Rosenbaum S, et al. An examination of the anxiolytic effects of exercise for people with anxiety and stress-related disorders: a meta-analysis. Psychiatry Research. 2017;249:102–108. doi:10.1016/j.psychres.2016.12.020
- Lopresti AL, Smith SJ. The effects of a saffron extract (affron) on menopausal symptoms in women during perimenopause: a randomised, double-blind, placebo-controlled study. Journal of Menopausal Medicine. 2021;27(2):66–78. doi:10.6118/jmm.20034
- Shafiee A, Jafarabady K, Seighali N, et al. Effect of saffron versus selective serotonin reuptake inhibitors (SSRIs) in treatment of depression and anxiety: a meta-analysis of randomised controlled trials. Nutrition Reviews. 2025;83(3):e751–e761.
- Hunter MS. Cognitive behavioral therapy for menopausal symptoms. Climacteric. 2021;24(1):51–56. doi:10.1080/13697137.2020.1777965
- Schmidt PJ, Ben Dor R, Martinez PE, et al. Effects of estradiol withdrawal on mood in women with past perimenopausal depression: a randomized clinical trial. JAMA Psychiatry. 2015;72(7):714–726. doi:10.1001/jamapsychiatry.2015.0111
- Maki PM, Kornstein SG, Joffe H, et al. Guidelines for the evaluation and treatment of perimenopausal depression. Menopause. 2018;25(10):1069–1085.
Explore our range of science-backed, natural treatments for menopause symptoms.
01
What it actually feels like
Perimenopausal anxiety often arrives in a recognisable pattern that distinguishes it from generalised anxiety disorder:
- New or sharply worse anxiety in your 40s, often without an obvious life trigger
- Cyclical or unpredictable intensity — worse in some weeks than others, often tied to the late luteal phase before periods change
- Physical symptoms first — palpitations, chest tightness, nausea, difficulty breathing — sometimes mistaken for cardiac events
- Night-time waking with anxiety at 3–4 am, often paired with hot flushes
- Intrusive worries that feel out of proportion to circumstance
- A sense of "not being yourself" — irritability, low frustration tolerance, emotional volatility
The day-to-day variability is the strongest clue. Generalised anxiety is more consistent; perimenopausal anxiety surges and recedes with hormone fluctuations.
02
Why menopause causes anxiety
Four mechanisms drive it, often at the same time.

1. Oestrogen modulates mood-regulating neurotransmitters
Oestrogen directly influences serotonin, dopamine, and GABA, the three neurotransmitter systems most involved in anxiety and mood regulation.2 As oestrogen falls, serotonin production drops and GABA receptor sensitivity changes, which is why women with no prior anxiety history often develop it for the first time in perimenopause.
2. The HPA axis becomes more reactive
The hypothalamic-pituitary-adrenal (HPA) axis is the body's stress response system. Oestrogen normally has a damping effect on it. As oestrogen falls and fluctuates, cortisol responses become exaggerated, and the body stays in a higher baseline of physiological arousal.3
3. Sleep disruption amplifies everything
Hot flushes, night sweats, and oestrogen-driven sleep architecture changes mean most perimenopausal women lose deep sleep. Even one week of disrupted sleep significantly raises anxiety and emotional reactivity in controlled studies.4 Sleep loss is the single biggest amplifier of perimenopausal anxiety.
4. Progesterone withdrawal removes a natural calming signal
Progesterone metabolises into allopregnanolone, a compound that acts on GABA receptors with anxiolytic (anti-anxiety) effects. As progesterone fluctuates wildly and then falls in perimenopause, this natural calming signal becomes erratic.5
03
How it changes by menopause stage
The pattern is not the same across all of perimenopause and postmenopause.
Early perimenopause (cycles still mostly regular)
Mild new anxiety, often in the late luteal phase (week before period). PMS-like worsening that did not exist before. Sleep starting to fragment.
Late perimenopause (skipped periods, wildly variable cycles)
The peak of anxiety risk for most women. Oestrogen swings are largest and most unpredictable. Hot flushes intensify. Night-time anxiety and morning dread become more common.
Postmenopause (12+ months without a period)
Anxiety often settles within 2–3 years as oestrogen stabilises at its new lower baseline. Women who treated their symptoms (lifestyle, supplements, MHT) typically settle faster than those who pushed through.
This trajectory matters because the worst of the anxiety is usually time-limited. Knowing that does not make it easier to live through, but it can change the calculation about whether to treat.
04
What actually helps
Sleep is the lowest-hanging fruit
If you only do one thing, protect sleep. Address hot flushes (lighter bedding, cooler room, MHT consideration), keep alcohol out of the evening, and stop screen use before bed. Magnesium glycinate at 200–400 mg in the evening helps both sleep onset and the muscle tension that accompanies anxiety.
Movement matters more than most women realise
Regular exercise has antidepressant and anti-anxiety effects comparable to SSRIs in mild-to-moderate cases.6 A combination of resistance training (2–3 sessions per week) and aerobic exercise (3+ sessions per week) produces the largest effect. Walking outdoors adds the additional benefit of light exposure and stress reduction.
Saffron has surprisingly good evidence
A 2021 Australian-led trial of 86 perimenopausal women showed standardised saffron extract reduced anxiety scores by 33% and depression scores by 32% over 12 weeks.7 A 2025 meta-analysis comparing saffron to SSRIs found no significant difference in effectiveness for anxiety and depression, with saffron producing fewer adverse events.8 Read Saffron for Perimenopause for the dose, form, and timeline.
Cognitive behavioural therapy (CBT)
CBT specifically adapted for menopausal symptoms has strong evidence for both anxiety and hot flushes. It is available through specialist psychologists in Australia and through online programmes such as the UK NHS-developed Living Well Through Menopause.9
Menopausal Hormone Therapy (MHT)
For women with significant anxiety alongside other menopausal symptoms (hot flushes, sleep, mood), MHT often improves anxiety substantially, particularly when oestrogen is fluctuating widely. The mechanism is direct: stable oestrogen levels stabilise the neurotransmitter and HPA axis systems described above.10 The Australasian Menopause Society publishes plain-English guidance on candidacy.
Antidepressants (SSRIs and SNRIs)
For women whose anxiety extends beyond what other interventions can manage, or who have a history of mood disorders, low-dose SSRIs or SNRIs are well-studied and effective in perimenopause. They have the additional benefit of often improving hot flushes. This is a GP conversation, not a supplement substitute.
What does not help as much as the marketing suggests
- CBD without THC: limited evidence for anxiety in this population
- Generic "stress relief" multi-supplements: usually under-dosed and lacking specificity
- "Adrenal support" products: no evidence base for menopausal anxiety
- Cutting caffeine entirely: caffeine can worsen jittery anxiety, but moderate intake (1–2 coffees before noon) is fine for most women
05
When to see your GP
See your GP if:
- Anxiety is disrupting sleep most nights
- Panic attacks (sudden surges with palpitations, breathlessness, feeling of doom) are occurring
- You are using alcohol to manage anxiety
- Anxiety is significantly affecting work, relationships, or daily life
- You have any thoughts of self-harm or suicide (please go to your GP or emergency department today)
- You want to discuss MHT or prescription options
Own Your Menopause Appointment: 5 Tips from a GP walks through how to prepare so the conversation is productive. If your GP attributes everything to "stress" without considering perimenopause as the driver, ask for a referral to a menopause specialist or another GP with menopause training.
06
What to expect over time
For most women, perimenopausal anxiety follows a curve: it builds through early perimenopause, peaks in the late perimenopausal years, then settles over the first 2–3 years of postmenopause as oestrogen stabilises at its new baseline.11
The women who do best at the other end of that curve are the ones who took it seriously rather than waiting for it to pass. The interventions above work, the evidence is solid, and you do not have to push through several years of disrupted sleep and elevated anxiety to qualify for help. The earlier you treat it, the less it shapes the next phase of your life.
At Biolae, we’re here to support women through every stage of hormonal change with science-backed care, no judgment, and no guesswork. We believe education plays a powerful role in helping you understand what’s happening in your body and how to care for it.
Our content is guided by a commitment to clarity, trust, and evidence. Everything we share is reviewed for accuracy and informed by the latest clinical research and expert insight — so you can feel confident in every step you take with us.